Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The latest update is out from Inspira Technologies Oxy BHN ( (IINN) ).
Inspira Technologies has delivered its INSPIRA™ ART100 systems to Glo-Med Networks Inc, marking an important step in its U.S. market entry. The systems will be distributed to hospitals along the east coast and a leading cardiothoracic division in New York. This move is expected to introduce Inspira’s innovative technologies to key medical professionals and potentially transform acute respiratory care. The INSPIRA™ ART100, designed with state-of-the-art technology for cardiopulmonary bypass, and its integration with the HYLA™ blood monitoring technology, showcases Inspira’s commitment to revolutionizing patient care and its strategic growth in the respiratory support industry.
More about Inspira Technologies Oxy BHN
Inspira Technologies Oxy B.H.N. Ltd. is an innovative medical technology company specializing in life support and respiratory treatment solutions. The company has developed the INSPIRA™ ART, a breakthrough device targeting the $19 billion mechanical ventilation market by offering an alternative for patients with acute respiratory failure. The technology aims to stabilize oxygen levels without the need for mechanical ventilators, allowing patients to remain awake during treatment. Inspira’s products, including the INSPIRA™ ART100 system and the HYLA™ blood sensor, are designed to enhance patient care by providing real-time monitoring and support for informed medical decisions.
YTD Price Performance: 10.38%
Average Trading Volume: 136,726
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $21.48M
For detailed information about IINN stock, go to TipRanks’ Stock Analysis page.
